fdatapering

1 results found.

Top Stocks matching your search for "fda tapering"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0802/1302/1602/2202/2703/0203/0703/1003/1503/21
AKBA

Akebia Therapeutics Inc.

-38.05%

$1.13 - $0.70

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

Good FDA news -- stock is up!

Mar, 17, 2023

we can hear about FDAs decision anyday starting Th... See more

AKBA

Akebia Therapeutics Inc.

-38.05%

$1.13 - $0.70

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

Good FDA news -- stock is up!

Mar, 17, 2023

we can hear about FDAs decision anyday starting Thursday..exciting times ahead

Mar, 10, 2023

but a positive for the FDA as Dr. Stein looks at the label.

Feb, 26, 2023

*******” another BIG reason why the FDA should approve it!!! !

Feb, 25, 2023

Home run with FDA, path forward soon.

Feb, 24, 2023

And some are saying oh its just an opinion, this is actually fantastic news for us and will open the door to other countries for approval and HOPEFULLY the US fda will approve it.

Feb, 24, 2023

$AKBA We should be very happy at current recovery, Im holding the rest of my position right into partner, FDA the lot Yesterdays news was amazing

Feb, 24, 2023

It is clean for the FDA.

Feb, 24, 2023

This bodes very well for fda FDRR approval.

Feb, 24, 2023

$AKBA FDA, please listen and read: “The benefit of Vafseo is its ability to correct haemoglobin levels in dialysis-dependent patients, with effects comparable to those seen with erythropoiesis-stimulating agents.